SOTIO to Present Poster on DUET-01 Clinical Trial at 2024 ASCO Annual Meeting
Business Wire
PRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group,..
PRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group,..
· There is currently no evidence-based treatment for the smallest babies with malaria
· The CALINA study tested a new..
*Ad hoc announcement pursuant to Art. 53 LR*
· *Q1 net sales grew +11% (cc*^*1**, +10% USD) with core operating income..